Retraction Note to: British Journal of Cancer (2005) 92, 1899–1905; https://doi.org/10.1038/sj.bjc.6602595, published online 3 May 2005
The authors have retracted this article because there are anomalies in the data presented in Figures 2, 3 and 6, namely:
-
Figure 2: apparent splicing between the KAT4 and K18 lanes, and lack of a background in the p85 row.
-
Figure 3 left panel: two apparently duplicated bands (lanes 2 and 6 and lanes 4 and 7) in the pAktS473 row.
-
Figure 6B: one apparently duplicated band (3 Days+KP372-1/WRO and 1 Day+KP372-1/NPA187).
As the original data are no longer available, the authors have requested that the article is retracted. S. Kim, M.N. Younes, S.A. Jasser, A.K. El-Naggar, G.B. Mills and J.N. Myers agree with this retraction. M. Mandal has not explicitly stated whether they agree with this retraction.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Mandal, M., Kim, S., Younes, M.N. et al. Retraction Note to: The Akt inhibitor KP372-1 suppresses Akt activity and cell proliferation and induces apoptosis in thyroid cancer cells. Br J Cancer 124, 1747 (2021). https://doi.org/10.1038/s41416-021-01299-9
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41416-021-01299-9
